Actualizado 04/12/2008 12:03
- Comunicado -

Results From the First and Largest Collaborative Study Confirm Role of Enbrel(R) in Psoriatic Arthritis (y 2)

    
    REFERENCES
    (1) Poster P29 from the Gene to Clinic meeting, December 2008. Sterry. W.
        et al. Results of a Randomized, Double-Blind Study to Evaluate the
        Efficacy and Safety of Etanercept in Patients with Psoriasis and
        Psoriatic Arthritis: The PRESTA Trial
    (2) Richards HL et al. The contribution of perceptions of stigmatization
        to disability in patients with psoriasis. J Psychosom Res.
        2001;50:11-15.
    (3) Poster P30 from the Gene to Clinic meeting, December 2008. Barker, J.
        et all. Improvement in the Dermatology Life Quality Index for
        Patients With Psoriasis and Psoriatic Arthritis Treated with
        Etanercept

For further information, please contact: Wyeth: Gill Markham, Communications - Europe, Middle East and Africa, Direct Tel: +44-1628-692536, Email: markhagl@wyeth.com; Danielle Halstrom, Communications - Global, Direct Tel: +1-484-865-2020, Email: halstrd@wyeth.com; OgilvyHealthPR: Mary Barrington-Ward, Tel: +44-207-108-6066, Email: mary.barrington-ward@ohpr.com; Nerea Hinzpeter, Tel: +1-212-625-4178, Email: Nerea.hinzpeter@ohpr.com

Contenido patrocinado